Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C

Tsugiko Oze,Naoki Hiramatsu,Nao Kurashige,Natsuko Tsuda,Takayuki Yakushijin,Tatsuya Kanto,Tetsuo Takehara,Akinori Kasahara,Michio Kato,Harumasa Yoshihara,Kazuhiro Katayama,Shinji Kubota,Taizo Hijioka,Kazunobu Ishibashi,Masahide Oshita,Hideki Hagiwara,Yoshimichi Haruna,Eiji Mita,Shinji Tamura,Norio Hayashi

Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C

2006

Background The aim of this study was to examine the factors correlated with the progression of ribavirin-induced hemolytic anemia in patients with chronic hepatitis C treated by interferon and ribavirin combination therapy.

Keywords:

Liver disease
Hemoglobin
Hepatitis C
Interferon
Immunology
Combination therapy
Hemolytic anemia
Ribavirin
Medicine
Diabetes mellitus
Surgical oncology
Hepatology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations